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Background: The purpose of this study was to further elucidate the role of the vascular smooth muscle cells (SMCs) in
abdominal aortic aneurysm (AAA) disease. We hypothesized that that AAA SMCs are unique and actively participate in
the process of degrading the aortic matrix.
Methods: Whole-genome expression proﬁles of SMCs from AAAs, nondilated abdominal aorta (NAA), and carotid
endarterectomy (CEA) were compared. We quantiﬁed elastolytic activity by culturing SMCs in [3H]elastin-coated plates
and measuring solubilized tritium in the media after 7 days. Matrix metalloproteinase (MMP)-2 and MMP-9 production
was assessed using real-time polymerase chain reaction, zymography, and Western blotting.
Results: Each SMC type exhibited a unique gene expression pattern. AAA SMCs had greater elastolytic activity than NAA-
SMCs (D68%; P < .001) and CEA-SMCs (D45%; P < .001). Zymography showed an increase of active MMP-2 (62 kD)
in media from AAA SMCs. AAA SMCs demonstrated twofold greater expression of MMP-2 messenger (m)RNA (P <
.05) and 7.3-fold greater MMP-9 expression (P < .01) than NAA-SMCs. Culture with U937 monocytes caused
a synergistic increase of elastolysis by AAA SMCs (41%; P < .001) but not NAA-SMCs or CEA-SMCs (P [ .99).
Coculture with U937 caused a large increase in MMP-9 mRNA in AAA-SMCs and NAA-SMCs (P < .001). MMP-2
mRNA expression was not affected. Western blots of culture media showed a fourfold increase of MMP-9 (92 kD)
protein only in AAA-SMCs/U937 but not in NAA-SMCs/U937 (P < .001) and a large increase in active-MMP2 (62
kD), which was less apparent in NAA-SMCs/U937 media (P < .01).
Conclusions: AAA-SMCs have a unique gene expression proﬁle and a proelastolytic phenotype that is augmented by macro-
phages. This may occur by a failure of post-transcriptional control of MMP-9 synthesis. (J Vasc Surg 2014;60:1033-42.)
Clinical Relevance: The only current therapeutic modalities for treatment of the abdominal aortic aneurysm rely on
physical exclusion of the aneurysmdtherapies associated with substantial risks and costs. Medical therapies that block the
progressive destruction of the aortic wall have great potential to reduce the need for surgical treatment. The experiments
in this study demonstrate that the intrinsic smooth muscle cells in the wall of the aneurysmal aorta are uniquely capable of
enzymatic destruction of elastin and potentiate the elastolytic capability of the inﬂammatory cells. Effective therapy for
aneurysms may require treatments targeting the dysfunctional activities of the intrinsic smooth muscle cells.The aortic aneurysm remains a poorly understood wall and is capable of (1) matrix synthesis, (2) protease or
inﬂammatory, matrix-degenerative disease that results in
signiﬁcant morbidity and mortality. The vascular smooth
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may be related to the loss of synthetic capability due to
apoptosis or other mechanisms,1,2 but there is also growing
evidence that aortic VSMCs have the potential to directly
participate in the degenerative process.3-5 In addition, the
unique predilection of aneurysms for the infrarenal aorta
and adjacent iliac vasculature could be related to regionali-
zation of the intrinsic cellular components.6-10
We hypothesized that the VSMCs isolated from aortas in
patients with abdominal aortic aneurysms (AAAs) would
demonstrate a unique pattern of gene expression compared
with cells derived from the nondilated infrarenal aorta under
identical culture conditions. We also hypothesized that this
expression phenotype would manifest with increased direct
and indirect elastolytic activity compared with VSMCs derived
from nonaneurysmal aortic wall or even pathologically altered
VSMCs derived from atherosclerotic plaque. In this study, we
compared whole genome gene expression patterns of the
explanted VSMCs from each of these tissues, directly
measured their ability to degrade elastin, and characterized
speciﬁc pathways and enzymes that are involved in this process.
METHODS
Human tissues were collected anonymously under an
exempt protocol approved by the Washington University
Institutional Review Board. Details of the methods of analysis
can be found in the Supplementary Methods (online only).
Microdissection and RNA extraction. Brieﬂy, frozen
sections from AAA specimens were microdissected using
a PixCell IIe system (Arcturus Bioscience Inc, Mountain
View, Calif). Each histologic layer of the aortic wall (intima,
media, and adventitia) was identiﬁed and separately
dissected onto “caps,” ensuring no incidental attachment
of adjacent tissue. Tissue from ﬁve serial sections was
combined and RNA extracted using the PicoPure RNA
Kit (Arcturus). The complementary (c)DNA was ampliﬁed,
and the HG-U133 Plus GeneChip (Affymetrix, Santa Clara,
Calif) was used for the hybridization and normalized across
microarrays using the Robust MultiChip Average program.
One-way analysis of variance (ANOVA) was performed
using a conservative signiﬁcance cutoff to identify informa-
tional genes that distinguished between the three cell
classesdadventitia, media, and intimadusing a microarray
analysis suite (Partek Inc, St. Louis, Mo; www.partek.com).
Cell culture. Brieﬂy, anonymous discard tissues of
nondilated abdominal aorta (NAA), AAA, and carotid pla-
que were used. The intimal layer was removed from the
aortic tissue. The tissue was digested with collagenase
type I (Worthington Biochemical, Lakewood, NJ) and
porcine pancreatic elastase (Sigma-Aldrich, Saint Louis,
Mo). The cells were suspended in Dulbecco’s modiﬁed
Eagle’s medium containing Smooth Muscle Cell Growth
Supplement (ScienceCell, Carlsbad, Calif) with 10% fetal
calf serum, GlutaMAX I (Life Technologies, Grand
Island, NY), nonessential amino acids, 6 mM N-2-
hydroxyethylpiperazine-N 0-2-ethanesulfonate, and antibi-
otics. Samples of cells (passage less than ﬁve) were analyzed
by ﬂow cytometry for cell type-speciﬁc marker proteins.U937 cells for use in the elastolytic assays were
cultured in Roswell Park Memorial Institute media con-
taining 10% fetal bovine serum and antibiotics. Before
use in our experiments, the cells were differentiated in
media containing 10-nM phorbol 12-myristate 13-acetate
(Sigma-Aldrich) for 24 hours.
Expression proﬁling. Whole genome gene expression
proﬁles of VSMCs were analyzed in two independent
batches. Total RNA was extracted and analyzed on the
Human HT-12 v4 Expression BeadChip (Illumina, San
Diego, Calif), according to the manufacturer’s instructions.
The expression data were normalized in BeadStudio
software (Illumina) using the cubic-spline method. The
data were then imported into Partek Genomics Suite 6.5
(Partek Inc). Differential gene expression analysis was per-
formed using a mixed-model ANOVA. A gene list was then
created using a median false discovery rate of 0.05. Inclu-
sion of patient age and sex did not inﬂuence the model.
Genes that were differentially expressed in VSMCs derived
from AAAs compared with VSMCs from CEAs and NAAs
were subjected to gene ontology analysis.
Class prediction analysis was based on k-nearest
neighbor classiﬁcation (k ¼ 1 and k ¼ 3, based on a
Euclidean distance measure). The misclassiﬁcation rate of
each model was estimated using complete leave-one-out
cross-validation.
Elastolytic activity. Tritiated elastin (Moravek
Biochemicals, Brea, Calif) was prepared as described previ-
ously.11 Tissue culture wells (24/plate) were coated with
200 mg [3H]elastin. Coculture experiments were per-
formed using a Transwell coculture system (Corning Inc,
Big Flats, NY). The VSMCs were incubated for 24 hours in
serum-free Dulbecco’s modiﬁed Eagle’s medium con-
taining 20 mg/mL lipopolysaccharides (Sigma-Aldrich).
Experiments were performed with 1  105 cells in the well
or with 0.5  105 cells in the transwell, or both, for 7 days
before the solubilized [3H]elastin was quantitated by
counting an aliquot of the media in a b-scintillation
counter. All assays were performed with three technical
replicates. Activity is reported in total micrograms of elastin
degraded per well based on the speciﬁc activity of [3H]
elastin.
Degradation of mouse aortic elastin ex vivo. Serial
sections of optimal cutting temperature-embedded in-
frarenal aortic tissue from C57/Bl6 mice (The Jackson
Laboratory, Bar Harbor, Me) were mounted on coverslips.
The sections were examined using an Olympus BX61
ﬂuorescence microscope (Olympus, Center Valley, Pa) at
original magniﬁcation 200. The tissue sections were
cultured for 10 days with VSMCs derived from AAA or
NAA tissue and reimaged.
Measurement of metalloproteinase production.
Evaluation of matrix metalloproteinase (MMP) production
and activity were performed as previously described.11
Brieﬂy, the VSMCs cultured from AAA, CEA, and NAA
tissue were plated in six-well culture plates (Corning) at
a density of 0.5  106 and incubated in serum-free media
for 7 days. For coculture experiments, activated U937 cells
Table I. Characteristics of patients from which vascular
smooth muscle cells (VSMCs) were harvested for
microarray analysisa
Tissue type No.
Age, years Sex, % Cell passage, No.
Mean (SE) Male Female Mean (SE)
AAA 22 69.8 (1.9) 76 24 2.8 (0.16)
NAA 17 45.6b (4.1) 47 53 2.2 (0.12)
CEA 29 67.0 (2.0) 53 47 2.6 (0.21)
AAA, Abdominal aortic aneurysm; ANOVA, analysis of variance; CEA,
carotid endarterectomy; SE, standard error.
aVSMCs were cultured from AAA, NAA, and CEA tissues.
bP < .001, ANOVA with Tukey post-hoc test.
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protein were resolved on 4% to 20% gradient gels or 12.5%
gels containing 0.2% gelatin. The zymogram gels were
incubated overnight in assay buffer and then rinsed with
deionized water and stained with Coomassie Blue.
Western blotting was performed on proteins that were
transferred to nitrocellulose, blocked in 5% nonfat dried
milk in phosphate-buffered saline with Tween 20 buffer
for 1 hour at room temperature, and incubated with
primary antibody toward MMP-2 or MMP-9 (ab37150,
ab38898; Abcam, Cambridge, Mass) overnight. A
peroxidase-chemiluminescent system (GE Healthcare,
Pittsburgh, Pa) was used to detect bound primary.
Expression of MMP-2 and MMP-9 mRNA in VSMCs was
compared by quantitative real-time polymerase chain
reaction (assay ID: Hs01548727_m1, Hs00234579_m1,
and Hs02758991_g1, respectively; Applied Biosystems,
Grand Island, NY). Gene expression in AAA-VSMCs and
CEA-VSMCs relative to NAA-VSMCs was calculated
using the 2DDCT method.
Statistics. For analysis of the elastolytic assay data,
a one-way ANOVA was performed, using SPSS 19 soft-
ware (IBM Corp, Armonk, NY), comparing mean micro-
grams of elastin degraded and mean MMP-2 and MMP-9
production between experimental groups. The Tukey post-
hoc test was used to compare mean micrograms of elastin
degraded between the individual groups within experi-
ments. The same analysis was done to compare MMP
production in Western blotting.
RESULTS
Characterization of cells. Cell cultures were obtained
by enzymatic explantation techniques from fresh tissues
discarded after surgery under a Humans Studies
Committee protocol. All VSMC cultures used in experi-
ments were negative by ﬂow cytometry for cell markers
CD11c, CD20, CD3, CD31, and CD68 and were positive
for a-smooth muscle actin.
Expression proﬁles of VSMCs in culture. We per-
formed gene expression proﬁle analyses from 22 AAAs,
29 CEAs, and 17 NAA VSMC lines, representing all avail-
able cell lines produced at the time of analysis. Characteris-
tics of the patients from which the tissue was harvested are
summarized in Table I. The mean age of patients with
AAAs and CEAs was similar. Patients from whom NAA
tissue was harvested were generally younger than the CEA
or AAA patients. Most of the AAA patients were male. The
distribution of male and female patients was approximately
equal for NAA and CEA patients.
Using a false discovery rate of <0.05, we identiﬁed 816
genes that were differentially expressed by the VSMCs
derived from these tissue types. A principal component anal-
ysis plotted based on those genes is shown in Fig 1,A. In the
principal component analysis, the three distinct clusters
clearly show the unique gene expression pattern of the cells
derived from aortic aneurysm tissue, and hierarchical clus-
tering further demonstrates the very distinct pattern of
aneurysm-derived cell types.We were able to validate the application of gene expres-
sion proﬁling to discriminate among VSMCs derived from
AAA, CEA, and NAA tissue with high accuracy using a class
prediction analysis based on k-nearest neighbor classiﬁca-
tion (k ¼ 1 and k ¼ 3). Models were constructed contain-
ing a range of predictor genes. After cross-validation with
leave-one-out cross-validation, the mean percentage of
correct classiﬁcation of the VSMC subsets (AAA, NAA,
CEA) by these models ranged from 73% to 90% with the
three-nearest neighbor classiﬁcation containing 30
predictor genes performing most accurately. Table II
outlines the performance of this model. The model
correctly classiﬁed 20 of 22 AAA VSMC cell lines (91%),
14 of 18 (82%) NAA VSMC cell lines, and 27 of 29
CEA VSMC cell lines (93%).
Expression proﬁles of microdissection of AAA
wall. Ampliﬁed RNA from microdissection specimens of
the three principal layers of the aortic walldintima,
media, and adventitiadunderwent microarray analysis.
We performed cluster analysis of these data to resolve
whether there are consistent differences in expression
that would allow us to speciﬁcally group the microdis-
sected layers of the aortic wall. We identiﬁed 49 genes
that highly signiﬁcantly (P < .0005) differentiated among
these three layers of the aortic wall (Supplementary Fig 1,
online only).
Gene ontology. Gene ontology analysis revealed that
a number of functional classiﬁcation groups were expressed
differentially in AAA-derived VSMCs compared with NAA
and CEA VSMCs. Some of the most signiﬁcantly enriched
functional categories included genes related to axis speci-
ﬁcation, response to oxidative stress, proapoptotic path-
ways, the proliferation and migration of VSMCs, several
proinﬂammatory pathways, and proteolysis.
Our microarray data revealed a signiﬁcant elevation of
MMP-2 and MMP-9 mRNA expression in AAA-derived
VSMCs relative to VSMCs cultured from NAA and CEA
tissue. Analysis of the microarray data also suggested signif-
icantly increased expression of the cysteine proteases,
cathepsin B, cathepsin L, cathepsin K, and cathepsin S.
The data did not reveal differences in expression of the
endogenous MMP inhibitors tissue inhibitor of metallo-
proteinase (TIMP)-1 and TIMP-2 or the cysteine protease
Fig 1. A, Principal components analysis and hierarchical clustering demonstrate distinct gene expression patterns of
cultured vascular smooth muscle cells (VSMCs) derived from abdominal aortic aneurysm (AAA, n ¼ 22; red), non-
dilated infrarenal aorta (NAA, n ¼ 17; green), and carotid endarterectomy (CEA, n ¼ 29; blue) tissues. B, Microarray
data demonstrate relative gene expression of speciﬁc elastases and inhibitors between VSMCs cultured from AAA (n ¼
22), NAA (n ¼ 17), and CEA (n ¼ 29) tissues. C and D, AAA-derived tissues exhibited signiﬁcantly increased gene
expression of several elastin-degrading endopeptidases, including matrix metalloproteinase (MMP)-2, MMP-9,
cathepsin-B, cathepsin-L, and cathepsin-K. *P < .05, **P < .01, analysis of variance (ANOVA).
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TIMP-3 by AAA VSMCs was increased (Fig 1, B).
Enhanced elastolytic activity of AAA-derived
SMCs. Elastolytic activity of these cells (n ¼ 11 per tissue
type) was assayed by culturing the cells on [3H]-labeled
elastin-coated plates for 7 days. Cells derived from AAA
consistently degraded signiﬁcantly more elastin than cells
derived from NAA (18.9 6 5.5 vs 6.1 6 3.9 mg; P < .001)
and CEA (10.45 6 5.5 mg; P ¼ .001; Fig 2, A).
The addition of inhibitors to the media of NAA and
CEA cells, consisting of BB-94 (a nonselective MMP
inhibitor, 5 mM), aprotinin (a serine protease inhibitor,
100 mg/mL), and E64 (a cysteine protease inhibitor,
10 mM), did not have a signiﬁcant effect on elastolytic
activity. In AAA-derived cells, however, MMP inhibition
with BB-94 inhibited elastolysis by w60% (7.6 6 0.9 vs
18.9 6 5.5 mg, n ¼ 3; P ¼ .008). Aprotinin and E64did not result in signiﬁcant reductions in elastolytic activity
degrading, at 11.3 6 2.6 vs 18.9 6 5.5 mg (n ¼ 3; P ¼
.09) and 14.9 6 2.7 vs 18.9 6 5.5 mg (n ¼ 3; P ¼ .55),
respectively (Fig 2, C and D). Elastin degradation by
VSMCs required direct contact because cells suspended
in transwell inserts above the [3H]elastin resulted in low
levels of elastolysis in VSMCs derived from NAAs (5.0 6
2.9 mg), CEAs (5.8 6 4.2 mg), and AAAs (6.0 6
4.8 mg; n ¼ 6).
MMP-2 and MMP-9 in conditioned media. A band
consistent with pro-MMP-2 was detected by zymography
and by Western blotting in conditioned media from the
VSMCs. There was no signiﬁcant difference in the VSMC
production of pro-MMP-2 among the tissue of origin
groups.
Active MMP-2, visualized as a 62-kD band on the
gelatin zymogram, was most pronounced in VSMCs
Table II. Performance of class prediction analysis (k-nearest neighbor [k ¼3]) for 30 predictor genes
Tissue type No. Proportion Correct Errors Correct, % Error, % SE, %
NAA 17 0.25 14 3 82.00 18l.00 9.25
CEA 29 0.43 27 2 93.00 7.00 4.71
AAA 22 0.32 20 2 91.00 9.00 6.13
Total 68 1 61 7 89.71 10.29 3.69
Confusion matrix (real/predicted) NAA CEA AAA
NAA 14 1 2
CEA 2 27 0
AAA 1 1 20
AAA, Abdominal aortic aneurysm; CEA, carotid endarterectomy; NAA, nondilated abdominal aorta; SE, standard error.
JOURNAL OF VASCULAR SURGERY
Volume 60, Number 4 Airhart et al 1037derived from AAA tissue, whereas very little active MMP-2
was detected in VSMCs derived from NAA and CEA tissue
(Fig 3, A). A band consistent with activated MMP-2 was
not seen on Western blotting, however, for any of the
VSMC groups (Supplementary Fig 2, online only). A low
level of MMP-9 was detectable by zymography (but not
by Western blotting) in the conditioned media from
AAA-derived and CEA-derived VSMCs, but no band was
seen at 92-kDa in the NAA-derived VSMCs.
Elastolysis in VSMC-macrophage cocultures. We
analyzed elastolytic activity in a coculture system where
VSMCs were cultured in the presence of phorbol 12-
myristate 13-acetate-activated U937 cells suspended in
transwell inserts. In cocultures containing AAA-derived
VSMCs with U937 cells, a >40% increase in elastolytic
activity occurred compared with cultures containing AAA-
derived VSMCs alone (26.676 8.2 vs 18.96 5.5 mg, both
n ¼ 11; P < .001). In contrast, elastolytic activity was not
signiﬁcantly affected with the addition of U937 cells to
NAA-derived (6.83 6 5.38 vs 6.09 6 3.89 mg, both n ¼
11; P > .99) or CEA-derived (11.81 6 4.24 vs 10.45 6
5.40 mg, both n ¼11; P ¼ .99) VSMC cultures (Fig 2, D).
Elastolytic activity was also measured in cocultures with
U937 cells plated on the radiolabeled [3H]elastin with the
VSMCs suspended in transwell inserts (Fig 2, E). When
cultured alone in contact with insoluble elastin, the acti-
vated U937 cells exhibited only a small amount of elasto-
lytic activity (3.3 6 2.9 mg/well, n ¼ 3). We similarly
saw relatively little elastolytic activity of the VSMCs,
regardless of tissue of origin, when cultured in the transwell
alone and not in contact with the elastin. Coculturing
NAA-derived or CEA-derived VSMCs with the U937 cells
did not signiﬁcantly augment elastin degradation compared
with either cell type alone. When AAA-derived VSMCs
were suspended above the U937 cells in transwell inserts,
there was an approximate sixfold increase in elastolytic
activity compared with VSMCs in the transwell alone
(19.0 6 3.55 mg, n ¼ 7; P < .001) and compared with
activated macrophages alone (P < .001).
MMP-2 and MMP-9 in cocultures. Zymography
using conditioned media from activated U937 monocytes
demonstrated the presence of proenzyme forms ofMMP-9 and MMP-2 (Fig 3, A). The VSMC cultures
demonstrated relatively little MMP-9 activity, but all cell
lines showed activity at 72 kDa, consistent with pro-
MMP-2. The AAA-derived and CEA-derived cell lines
appeared to have more MMP-2 activity than the NAA-
derived cells, including the presence of activated MMP-
2. Culturing the VSMCs in the presence of U937 cells
in transwells led to increased amounts of active MMP-2 in
the culture media (62-kDa band) in all VSMC types
relative to VSMCs cultured alone. This effect was much
more pronounced with AAA-derived and CEA-derived
VSMCs than with NAA-derived VSMCs (Fig 3, A).
Signiﬁcant amounts of MMP-9 were detected in all wells
containing U937 cells.
Western blotting of conditioned media from cocultures
containing AAA-derived VSMCs demonstrated a uniformly
higher concentration of MMP-9, with a mean relative
density 3.8-fold greater than in NAA-U937 cocultures
(n ¼ 6; P < .001; Fig 3, D). In concordance to our results
from gelatin zymography, media from wells containing
cocultured U937 and VSMCs consistently demonstrated
the presence of active MMP-2, with a band at 62 kDa.
Once again, the increase of active MMP-2 was most
pronounced in cocultures containing AAA-derived VSMCs.
The density of the band corresponding to active MMP-2
was approximately six times that of the band observed for
NAA-VSMC cultures (n ¼ 6; P ¼ .01; Fig 3, D).
MMP-2 and MMP-9 expression. Under basal condi-
tions, the level of MMP-2 and MMP-9 mRNA expression
was signiﬁcantly higher in the AAA-derived VSMCs. Cells
cultured from AAA tissue exhibited twofold higher
expression of MMP-2 compared with NAA-derived
VSMCs (n ¼ 11; P < .05) and 7.3-fold increased expres-
sion of MMP-9 mRNA (n ¼ 11; P < .01; Fig 3, B).
The presence of U937 cells suspended in transwell
inserts did not increase VSMC expression of MMP-2
mRNA. In fact, MMP-2 expression decreased by a small
but statistically signiﬁcant amount (n ¼ 3; P < .05). Cocul-
ture with U937 monocytes led to a large relative increase
in the expression of MMP-9 mRNA in AAA and
NAA VSMCs (n ¼ 3; P < .001; Fig 3, C). MMP-2
and MMP-9 mRNA production by U937 cells was
Fig 2. A, Insoluble [3H]elastin digestion (mg 6 standard error [error bars]) by vascular smooth muscle cells (VSMCs)
from abdominal aortic aneurysm (AAA, n ¼ 11), nondilated abdominal aorta (NAA, n ¼ 11), and carotid endar-
terectomy (CEA, n ¼ 1) plaque cultured for 7 days. The AAA-derived cells degraded signiﬁcantly more [3H]elastin
than VSMCs cultured from CEA or NAA tissue. B, VSMCs cultured from NAA and AAA tissues were cultured for
10 days with mouse aortic tissue imaged with autoﬂuorescence before and after. Representative images demonstrate
diminished elastin in aortic tissue incubated with AAA-derived VSMCs. C, The effect of speciﬁc proteinase inhibitors
on the in vitro degradation of insoluble [3H]elastin. VSMCs derived from AAA, NAA, and CEA (n ¼ 3 each) were
cultured in serum-free media in the presence or absence of BB-94 (a broad inhibitor of matrix metalloproteinases
[MMPs], 5 mM), aprotinin (a serine protease inhibitor, 100 mg/mL), and E64 (cysteine protease inhibitor, 10 mM).
Only BB-94 signiﬁcantly reduced the elastin degraded by AAA-derived VSMC.D, The effect of coculture of VSMCs in
contact with [3H]elastin with activated U937 macrophages in transwells. VSMCs (n ¼ 11 each) were plated in [3H]
elastin-coated culture wells for 7 days with activated U937 cells in transwell inserts. The shaded area of the histogram
represents monoculture, and the open area represents coculture conditions. The presence of activated U937 cells
signiﬁcantly increased elastin degradation only with AAA-derived VSMCs compared with monoculture of SMCs. E,
The effect of coculture of activated U937 macrophages in contact with [3H]elastin with VSMC in transwells is shown.
VSMCs derived from AAA (n ¼ 7), NAA (n ¼ 3), or CEA (n ¼ 3) were cultured for 7 days in transwells above [3H]
elastin-coated plates, with or without activated U937 cells. Cell origin had no effect on elastin degradation when the
VSMCs were not in contact with the elastin. However, elastin degradation was only signiﬁcantly increased in wells with
AAA-derived VSMCs in transwell coculture with activated U937 macrophages.
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(Supplementary Fig 3, online only).
DISCUSSION
AAA is a progressive degenerative disease of a major
vascular conduit with considerable impact on patient
mortality and health care costs. The aneurysmal change is
frequently localized to the infrarenal segment of the
abdominal aorta, although it can extend into the adjacent
common and internal iliac vessels. Development of a weak-
ened aortic wall is associated with severe destruction of the
medial elastic ﬁbers. This study sought to demonstrate that
the VSMCs that populate the aneurysm wall have a unique
phenotype that directly contributes to the pathogenesis of
the aneurysm. We also sought to develop a mechanistic
understanding of the role of the VSMC in the destruction
of medial elastin that characterizes AAAs.9The traditional hypothesis has been that the destruction
of extracellular matrix in AAAs is primarily a consequence of
an exuberant chronic inﬂammatory inﬁltrate that is respon-
sible for the elaboration of elastases and other proteases that
damage the medial matrix structure of the aorta.6 Substan-
tial work has shown that the intramural macrophages may
have a central role,1-5,7-9 but more recent studies have
also focused on the contributions of neutrophils,11,12
mast cells,13,14 and other inﬁltrating cells.15,16 Much of
the supporting evidence for the central role of inﬂammation
in AAAs comes from mouse models, where nearly all
manners of anti-inﬂammatory therapy inhibit aneurysm
formation.17-19 In humans, however, anti-inﬂammatory
treatment has not been similarly successful.20
The VSMCs of the aorta have received less attention
than inﬂammation as a contributor to aneurysmal change.
Some studies have shown potential secondary participation
Fig 3. A, Gelatin zymography of conditioned cell culture media. Vascular smooth muscle cells (VSMCs) derived from
abdominal aortic aneurysm (AAA), nondilated abdominal aorta (NAA), and carotid endarterectomy (CEA) were
cultured in serum-free media for 7 days in the presence or absence of phorbol 12-myristate 13-acetate-stimulated U937
cells in transwell inserts. Media from cultures of SMCs alone was dominated by matrix metalloproteinase (MMP)-2
activity (62 kDa) particularly in the AAA-derived VSMCs. Media from cocultures demonstrated consistent bands
corresponding to MMP-9 activity (92 kD) and increased active MMP-2 activity relative to the monocultures, which
was most pronounced from AAA-derived VSMCs/U937 cocultures. B, Western blot analysis of conditioned cell
culture media for MMP-2 and MMP-9 from coculture experiments (representative blots are shown from n ¼ 6 for
densitometry for each). MMP-9 (92 kD) was more highly expressed in the media from cocultures with AAA-derived
VSMCs. The production of pro-MMP2 did not differ by SMC origin in the coculture setting. However, signiﬁcantly
more active MMP-2 (62 kD) was present in cultures containing AAA-derived VSMCs. C, Real-time polymerase chain
reaction in VSMCs from monoculture as well as in cells after coculture with activated U937 macrophages. At baseline,
MMP-2 and MMP-9 expression were both signiﬁcantly elevated in AAA-derived VSMCs relative to NAAs and CEAs.
In response to coculture with activated macrophages, MMP-9 expression increased dramatically in both NAA and AAA
VSMCs, whereas expression of MMP-2 messenger RNA (mRNA) signiﬁcantly decreased in both cell types under the
coculture conditions. *P < .05, **P < .01, analysis of variance (ANOVA) with Tukey post-hoc test.
JOURNAL OF VASCULAR SURGERY
Volume 60, Number 4 Airhart et al 1039of these cells in AAA pathogenesis due to a reduction in the
quantity or activity of medial VSMCs. The reduction in
VSMCs has been hypothesized to limit matrix repair in
the damaged aorta.21 There is also inferential evidence
that the VSMC may play a more direct role in aneurysm
formation.22
By examining the complete expression proﬁle of a large
number of pure, early-passage VSMC cultures from aneu-
rysmal and nonaneurysmal infrarenal aorta, we have shown
that VSMCs derived from AAAs exhibit a unique pattern
of gene expression that is distinct from VSMCs derived
from NAA tissue, with a high degree of predictability. The
microdissected aneurysm specimens suggested that the
expression proﬁles of the cells in the intima were distinct
from that of the media and adventitia in aortic specimens.
This would be consistent with a distinct process of disease
development of intimal atherosclerosis and aneurysmal dila-
tation. Therefore, to optimize the collection of aneurysm-
speciﬁc pathogenic cells, we grossly removed the intima
before cell culture of the aortic specimens Furthermore,we also compared the proﬁle of the aneurysm-derived
VSMC vs VSMCs derived from carotid plaque and
conﬁrmed that the proﬁle of the AAA cells was distinct
from that of atherosclerotic plaque, which further supports
the concept that the aneurysm cell phenotype is unique.
These crucial observations demonstrate that the AAA-
derived cells have an intrinsic or an acquired phenotype
that may contribute to the degeneration of the aorta. These
experiments cannot demonstrate how these AAA-derived
cells developed their unique phenotype or the mechanism
by which this phenotype persists relative to other VSMCs,
even when exposed to common in vitro culture conditions.
A detailed discussion of the potential sources of this unique
phenotype has been previously reviewed in detail.9
Brieﬂy, studies of the long-term growth characteristics of
aneurysm-derived VSMCs compared with similarly
cultured VSMCs from nonaneurysmal vasculature have
demonstrated consistent differences,21,23-25 even when
derived from the same patient.26 The speciﬁc ontogeny
of the distal aortic VSMC may also play an important
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to aneurysmal degeneration. It is notable that the external
iliac arteries, which are highly aneurysm-resistant, form
much later in gestation and from different precursors
compared with the adjacent dorsal aorta-derived and
aneurysm-prone infrarenal aorta, common iliac, and
internal iliac vessels.27,28
To understand how this novel phenotype of the AAA-
derived cells may predispose to AAA development, we
focused on determining the role of these cells with respect
to the elastic ﬁber degeneration characteristic of the AAA.
We conﬁrmed that within the aneurysm-speciﬁc expression
proﬁle is upregulation of several proteases of metallopro-
tease and cysteine classes that are capable of elastolysis.
Also potentially informative were the ﬁndings of the
MMP inhibitors, including a lack of upregulation of
TIMP-1 and TIMP-2, whereas there was considerable
upregulation of TIMP-3. The lack of increased TIMP-1
or TIMP-2 in the setting of increased MMP activity
suggests an imbalanced proteolytic state,29,30 although
the role of TIMP-3 is unclear. In whole aneurysm tissue,
others have shown signiﬁcantly increased expression of
TIMP-3 in AAAs,31 but gene expression32 and protein
production33 have both been shown to be decreased in
thoracic aortic aneurysms. This unique role of TIMP-3 in
AAA development is also supported by a genetic variant
of TIMP-3 (nt-1296) that has been found to be associated
with familial AAA.34
Of the elastolytic MMPs, only MMP-2 and MMP-9
demonstrated signiﬁcant upregulation in the AAA-derived
VSMCs, which we conﬁrmed by quantitative real-time
polymerase chain reaction. However, we also found signif-
icant upregulation of several cysteine proteases that are
capable of contributing to elastolysis. By incubating the
VSMCs on labeled insoluble elastin as well as murine aortic
sections, we conﬁrmed that the AAA-derived VSMCs were
able to degrade signiﬁcantly more insoluble elastin than
cells derived from nondilated infrarenal aorta or from
carotid plaque. The use of broad-spectrum class-selective
inhibitors showed this potent elastolytic activity appeared
to be primarily mediated by the activity of MMPs.
This critical ﬁnding conﬁrms our hypothesis that the
intrinsic VSMC found in the AAA can actively participate
in the matrix degradation process through MMP-
dependent elastolytic activity. However, it left open the
relative participation of aortic VSMCs and inﬂammatory
cells in the degradation of elastin. To evaluate the potential
interaction of VSMCs with macrophages in the degrada-
tion of elastin, we performed the coculture experiments
using activated U937 cells.35 Remarkably, the elastolytic
activity of AAA-derived VSMCs was substantially
augmented in the setting of coculture with the activated
macrophagesda synergistic effect not seen in coculture
with NAA-derived or CEA-derived cells.
The unique elastolytic activity of the AAA and macro-
phage cell coculture was associated with an incredibly large
increase in the expression of MMP-9 mRNA in the cocul-
tured VSMCs. At the same time, it was associated witha decreased expression of MMP-2 mRNA. Somewhat
surprisingly, we saw a nearly identical effect of coculture
on MMP expression in the cells derived from NAAdcells
that did not increase their elastolytic activity in coculture.
There was no appreciable effect on the mRNA expression
of MMP-9 or MMP-2 in the macrophages when cocul-
tured with VSMCs.
Despite the similar response of AAA-derived and NAA-
derived cells to MMP expression in the setting of activated
macrophages, coculture of the AAA-derived cells was asso-
ciated with a signiﬁcantly greater increase in MMP-9
protein in the conditioned media compared with the
NAA-derived cells. This would suggest substantial post-
transcriptional control of MMP-9 production occurs in
normal cells but is not effective in the AAA-derived
VSMCs. We also found substantially more activated
MMP-2 in the conditioned media from the AAA-derived
VSMCs cocultured with the activated U937.
CONCLUSIONS
Taken together, these data demonstrate that the
VSMCs that populate the AAA have a unique proelastolytic
phenotype that is augmented in the presence of activated
macrophages. This effect appears to occur by a post-
transcriptional failure of MMP-9 synthesis control leading
to increased production and activation of elastolytic
MMPs. These are unique and important ﬁndings regarding
the pathobiology of the disease that create new opportuni-
ties with respect to therapies that can result in effective
aneurysm inhibition. Further study is needed to determine
the intercellular and intracellular mechanisms that allow for
the synergistic overproduction of elastolytic proteases,
particularly MMP-9, by aneurysm-derived VSMCs in the
presence of activated macrophages.
We sincerely thank Stephen M. Schwartz, MD, PhD, at
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at www.jvascsurg.org.DISCUSSIONDr Frank LoGerfo (Boston, Mass). What comes ﬁrst? Do the
macrophages somehow change the phenotype of the smooth
muscle cells? I guess that’s the ﬁrst thing that comes to mind in
an inﬂammatory process. If so, then why do the macrophages
do that? What is the stimulus? Are there some receptors at theendothelial level? What causes the macrophages to get involved
here?
Of course, this could all be wrong. There could be a primary
phenotypic difference in the smooth muscle cells in the aortic wall
right from the start. But, it would seem more likely that the
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appreciate your thoughts about that.
Dr Nathan Airhart. Our hypotheses is that it may be the
smooth muscle cell that’s coming ﬁrst. As I discussed, the smooth
muscle cells that we are culturing from abdominal aortic aneurysms
are unique. They exhibit a unique phenotype in culture which
favors the degradation of elastin and this is a phenotype that
persists, even through several passages in cell culture. One poten-
tial explanation for this phenomenon may be that the smooth
muscle cells that populate the region of the infrarenal aorta have
a distinct embryologic origin. Interestingly, the embryologic
boundaries of these cells happen to match up with where more
than 90% of abdominal aortic aneurysms occur.
The nature of this study, and virtually all studies using patho-
logic specimens from human abdominal aortic aneurysm disease,
prevents us from answering the speciﬁc question, “which comes
ﬁrst, the inﬂammation or the smooth muscle cell,” as our cell
cultures are coming from very late-stage abdominal aortic aneu-
rysm tissue. However, the way that these cells from the infrarenal
aorta react to chronic stresses (abdominal aortic aneurysm risk
factors), such as smoking, atherosclerosis, or hemodynamic pres-
sure, may be different than smooth muscle cells from different
regions of the aorta or from those cells from individuals who do
not develop aneurysms.
Dr Alexander Clowes (Seattle, Wash). One of the obser-
vations made in the past is that the medial smooth muscle cells
die as aneurysms form. In our own studies of vascularadaptation, we have found that as smooth muscle cells undergo
apoptosis, they produce a lot of proteolytic activity and
degrade the surrounding matrix. It is very remarkable. I would
like to know whether the macrophages in your experiments are
killing the smooth muscle cells and whether the dying smooth
muscle cells are, in turn, secreting elastolytic and proteolytic
activity.
Dr Airhart. Currently, we do not have evidence that co-
culture with macrophages is inducing cell death in our smooth
muscle cells. We have not done objective studies to answer this
question, however, and it is something that we should look at
more closely.
Dr B. Timothy Baxter (Omaha, Neb). I have two questions
for you. Can you tell us about growing these cells out? Usually the
smooth muscle cells are much more difﬁcult to grow, and they
grow slower. And, so really you have two different populations.
And, I wonder if there is some selection in that process?
The second thing is activation of MMP-2. Did you happen to
look at MMP-14/MT1-MMP which is the activator of MMP-2?
Dr Airhart.We chose to focus on matrix metalloproteinase-2
and matrix metalloproteinase-9 after seeing the results from our
microarray data. We haven’t done any further validation with the
other MMPs.
We have had excellent success culturing smooth muscle cells
from the pathologic tissue. I think that this really comes from exten-
sive experience with the culture technique, careful attention to
tissue dissection, and maintenance of optimal culture conditions.
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Explant growth and initial characterization of cells
from arterial tissue. Human tissues were collected with
the approval and oversight of the Institutional Review
Board at Washington University. Anonymous discard
tissues were acquired from nondilated aortas during renal
transplantation (NAA) and open infrarenal aortic aneurysm
exclusion procedures (AAA). We obtained tissue from the
carotid intima removed during open carotid endarterec-
tomy procedures (CEA). These tissues consisted of full
thickness arterial wall, except the CEA specimens which
were predominantly intimal tissue. Fresh arterial tissue
was washed and the intimal layer was dissected free from
the aortic tissue and discarded. The remainder of the tissue
was dissected into small pieces approximately 5 mm3 in
size. The tissue was then transferred to a 50-mL conical
vial containing Dulbecco’s modiﬁed Eagle’s medium
(DMEM) with 3-mg/mL collagenase type I (290 U/
mg; Worthington Biochemical, Lakewood, NJ). It was
incubated for 30 minutes at room temperature while
undergoing gentile agitation. The supernatant was then
discarded and the tissue pieces were placed into media con-
taining collagenase and elastase (DMEM + 3-mg/mL
collagenase + 0.6-mg/mL type I porcine pancreatic elas-
tase; Sigma-Aldrich, St. Louis, Mo) and incubated at
room temperature with gentle agitation for 8 minutes.
The supernatant, containing dissociated cells was then
transferred into a 50-mL vial containing 7.5-mL fetal calf
serum. Additional collagenase/elastase media was then
added to the tissue pieces and this process was repeated
until approximately 100-mL dissociated cells were ob-
tained. The cell suspension was then centrifuged for 10
minutes and the supernatant was discarded. The cells
were suspended in smooth muscle cell growth media
(DMEM containing smooth muscle cell growth Supple-
ment (ScienceCell #1152, Carlsbad, Calif) with 10% fetal
calf serum, Glutamax I, nonessential amino acids, 6-mm
HEPES, 1000-IU/mL penicillin, and 1000-mg/mL strep-
tomycin (Life Technologies, Grand Island, NY). They were
plated into T-75 ﬂasks and incubated overnight at 37C
with 5% CO2. Cells in culture that reached approximately
80% conﬂuence were trypsinized and re-seeded at 1:3
into T-75 ﬂasks. All experiments were performed with cells
that had undergone no more than ﬁve passages.
U937 cells for use in the elastolytic assays were
cultured in Roswell Park Memorial Institute media con-
taining 10% fetal bovine serum, 1000-IU/mL penicillin,
and 1000-mg/mL streptomycin. Prior to use in our exper-
iments, the cells were differentiated in media containing
10-nM phorbol 12-myristate 13-acetate (PMA; Sigma-
Aldrich) for 24 hours.
Lineage marker analysis of tissue-derived smooth
muscle cells. An early passage (<three) of each culture
was analyzed by ﬂow cytometry to exclude the presence
of cell populations other than vascular smooth muscle cells
based on cell surface marker proteins CD11c, CD20, CD3,
CD31 and CD117. Each cell line was also evaluated for
intracellular alpha-actin after permeabilization with the
BD Cytoﬁx/Cytoperm kit (BD Biosciences, San Jose,
Calif).
Microdissection and RNA extraction. From the dis-
carded tissue in the central dilated portion of abdominal
aortic aneurysms a specimen was obtained. The tissues
were rapidly washed in sterile saline then divided into trans-
verse full-thickness blocks, embedded in optimal cutting
temperature in a chilled isopentane bath, and stored at
80C. These frozen tissues were sectioned and counter-
stained with Mayer’s hematoxylin using a rapid protocol-
modiﬁed for LCM. After air drying completely, the
specimen was then immediately microdissected using a Pix-
Cell IIe system (Arcturus, Oxnard, Calif). Each histologic
layer of the aortic wall (intima, media, and aventitia) was
identiﬁed and separately dissected onto “caps,” ensuring
no incidental attachment of adjacent tissue. During micro-
dissection, care was taken not to dissect within 10 to 20
microns of the intima-media interface or the media-adven-
titia interface in order to prevent contamination with cells
from the adjacent layer. It should be noted that to avoid
contamination between media and intima samples, the
dissection of the intima was primarily limited to the core
and cap regions of the plaque and no shoulder regions
were included in the dissection. Tissue from ﬁve serial
sections was combined, and these specimens were then
immediately processed using the PicoPure RNA Kit
(#KIT0204; Arcturus). The concentration and quality of
the RNA obtained was analyzed with an Agilent 2100 Bio-
analyzer using an RNA 6000 Nano LabChip. Samples were
selected for additional analysis based on these results where
RNA extractions from all layers of the wall demonstrated
28s/18s ribosomal RNA ratios greater than 2.0 and
showed relatively minimal degradation.
The cDNA was ampliﬁed with the Ovation/Biotin
system where it is also fragmented and labeled with biotin.
This product is then ready for hybridization to an Affyme-
trix GeneChip. For these studies the HG-U133 Plus Gen-
eChip was used for the hybridization. The GeneChip
hybridization signal was normalized across microarrays
using the Robust MultiChip Average program. One-way
analysis of variance (ANOVA) was performed using
a conservative signiﬁcance cut-off to identify informational
genes that distinguished between the three cell classes:
adventitia, media, and intima (Partek Pro microarray anal-
ysis suite; Partek Inc, St. Louis, Mo).
Expression proﬁling of smooth muscle cells. Whole
genome gene expression proﬁles of vascular smooth muscle
cells were analyzed in two independent batches. Total
RNA was extracted from cultures using Trizol LS Reagent
(Life Technologies, Grand Island, NY) according to the
manufacturer’s instructions and further puriﬁed with
RNeasy Spin Columns (Qiagen, Germantown, Md). The
integrity of the puriﬁed RNA was validated and quantiﬁed
using Lab-on-a-chip technology (Agilent Technologies
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microarray analysis (Illumina Total-Prep RNA Ampliﬁca-
tion Kit; Life Technologies, Grand Island, NY). Labeling
was achieved by the incorporation of biotin-16-UTP (Perkin
Elmer, Boston, Mass) at a ratio of 1:1 with unlabeled UTP.
Labeled product (400 ng per array) was hybridized to
a HumanHT-12 v4 Expression BeadChip according to the-
manufacturer’s instructions (Illumina, SanDiego, Calif) and
developed with ﬂuorolink streptavidin-Cy3. Arrays were
scanned with an Illumina Bead array reader confocal scanner
according to the manufacturer’s instructions.
The expression data were normalized in Illumina’s
BeadStudio software using the cubic-spline method. The
data was then imported into Partek Genomics Suite v6.5
(Partek Inc). Differential gene expression analysis was per-
formed using a mixed model ANOVA. The following
model was used: ygikj¼mg+Si+Tj+Pik+εgijk, where ygij is the
expression of the gth gene, ith tissue, jth batch, and kth
chip barcode. The symbols S, T, and P represent effects
due to tissue, batch, and chip barcode, respectively. The
error for the gth gene for sample ijk is designated as εgijk.
Batch is deﬁned as a group of samples that were hybridized
simultaneously. Chip barcode was included in the model to
account for any effect caused by variations in separate gene
chips. A gene list was then created using a median false
discovery rate of 0.05. Inclusion of patient age and sex
did not inﬂuence the model; therefore, they were not
included as variables.
In order to determine whether patterns in gene expres-
sion could accurately differentiate between vascular smooth
muscle cell (VSMC) derived from the three tissue types,
a class prediction analysis was performed using Partek
Genomics Suite (Partek Inc). Models were developed
based on k-nearest neighbor classiﬁcation (k¼1 and k¼3,
based on a Euclidean distance measure). Separate models
were constructed containing a range of genes which were
found to be the most signiﬁcantly different between the
classes as assessed by one-way ANOVA (top 10, 20, 30,
40, 50, 60, 70, 80, 90, 100, 200, 300, 400, 500, 600,
700, 800, 900, 1000 genes). Therefore, a total of 38
models were constructed. The misclassiﬁcation rate of
each model was estimated using complete leave-one-out
cross-validation.
Genes that were differentially expressed in VSMCs
derived from AAA compared to VSMCs from CEA and
NAA were subjected to gene ontology analysis using Partek
software to ﬁnd enriched gene groups according to their
biological or molecular function.
Elastolytic activity assay. Assays were performed to
compare the elastolytic activity of VSMCs derived from
AAA, CEA, and NAA tissue. We also measured the elasto-
lytic activity of these cells in a co-culture system with PMA-
stimulated human monocytes (U937 cells). Cells for use in
this set of experiments were selected on the basis of fresh
availability at passages 2 to 5 when the experiments were
performed. The selection of these cells for assay was not
inﬂuenced by the results of the gene array analyses. Triti-
ated elastin, which had been prepared as described
previously, was purchased from Moravek Biochemicals
(Brea, Calif).20 Incorporation of tritium was veriﬁed by
complete degradation of an aliquot of the labeled elastin
with porcine pancreatic elastase (PPE; Sigma-Aldrich)
compared to control exposed only to collagenase. In
a microcentrifuge tube, 200 mg of elastin was incubated
with 3-mg PPE in elastase buffer (100-mm Tris pH 8.0,
50-mm CaCl2) at 37 degrees C for 24 hours. The tube
was then centrifuged at 10,000g for 10 minutes. One-
hundred microliters of the supernatant were transferred
to a scintillation vial, and radioactive activity was quantiﬁed
using a b-scintillation counter. Speciﬁc activity was calcu-
lated by dividing the total cpm of the supernatant by the
number of micrograms used in the elastolytic reaction
(200 mg).
Tissue culture wells were coated with [3H] elastin. The
[3H] elastin was suspended in water at a concentration of 2
mg/mL, and 100 mL of the suspension (containing 200-
mg elastin) was pipetted into 24-well cell-culture plates
(Corning Inc, Big Flats, NY), coating the entire base of
the well. The elastin was allowed to dry and adhere to
the base of the well overnight.
Prior to use in this assay, VSMCs were incubated for 24
hours in serum-free DMEM containing 20mg/mL lipopoly-
saccharide (LPS) (#L3024; Sigma-Aldrich). They were then
seeded in [3H]-treated 24-well culture plates at a density of
1 x 105 cells per well, containing serum-free DMEM.
VSMCs were co-cultured with PMA-activated U937 cells
using a Transwell co-culture system (#3415; Corning Inc,
Big Flats, NY). After 24 hours of PMA activation, U937
cells were seeded at a density of 0.5 ✕ 105 cells in the trans-
well or 1 x 105 cells on the [3H]-treated culture plates.
VSMCs were seeded at a density of 0.5 ✕ 105 within the
transwell or 1 ✕ 105 cells on the [3H]-treated culture plates.
To determine the nonspeciﬁc release of radioactive elastin,
we used wells containing only cell-free medium. We also
used wells containing cell-free media with 50-mg porcine
pancreatic elastase to provide a measure of complete elastol-
ysis (Sigma-Aldrich). After 7 days in culture, the media was
collected from each well, centrifuged at 10,000 g for 10
minutes, and the solubilized [3H]-elastin was quantitated
by counting an aliquot of the media in a b-scintillation
counter. All assays were performed in triplicate, and the
mean scintillation count from the three wells was used in
all comparisons. Activity is reported in total micrograms
elastin degraded per well. This was calculated as follows:
(cpm sample e cpm cell free media)O (speciﬁc activity
of [3H] elastin)
Degradation of mouse aortic elastin ex vivo. Infrare-
nal aortic tissue was harvested from C57/Bl6 mice (Jack-
son Labs, Bar Harbor, Me) and embedded in optimal
cutting temperature compound and frozen in liquid
nitrogen. The tissue was serially sectioned into cryosections
20 uM in thickness and mounted on coverslips. The
sections were then examined using a ﬂuorescence micro-
scope (Olympus BX61, Center Valley, Pa), using a 20✕
objective and elastin was visualized by autoﬂuorescence
(BP 470-495). After initial imaging, the same tissue
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AAA or NAA tissue. VSMCs were plated in six-well culture
plates (Corning Inc, Big Flats, NY) at a density of 1 ✕ 106
cells per well. After 24 hours, the coverslip with the mouse
aorta section was placed into the culture well. The cover-
slips were removed from the culture media after 10 days
and elastin ﬁbers were re-examined using a ﬂuorescence
microscope.
Measurement of metalloproteinase production by
VSMCs.Tocompare relative amounts and activities ofmatrix
metalloproteinase (MMP)-2 and MMP-9 secreted by
VSMCs, conditioned media was subjected to gelatin zymog-
raphy. VSMCs cultured from AAA, CEA, and NAA tissue
were plated in 6-well culture plates (Corning Inc, Big Flats,
NY) at a density of 0.5 ✕ 106 and incubated in serum-free
media for 7 days. For co-culture experiments, PMA activated
U937 cells were suspended in transwells above the VSMCs at
a density of 3 ✕ 105. The media was then harvested and the
protein concentration was measured using the Quick Start
Bradford protein assay (Biorad, Hercules, Calif). Equal
amounts of protein were resolved on 12.5% sodium dodecyl
sulfate -polyacrylamide gels containing 0.2% gelatin. Proteins
were then renatured in 50mmol/L Tris buffer pH7.4 with
20%glycerol, and incubated overnight in assay buffer contain-
ing 0.1mol/L sodiumacetate buffer, pH5.5, 1mmol/L eth-
ylenediaminetetraacetic acid, and 2 mmol/L dithiothreitol.
The gels were then rinsed with deionized water and stained
with Coomassie Blue.
Equal volumes of VSMC and VSMC/U937 co-culture
conditioned media were subjected to sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (4%-20% gradient;
Life Technologies, Grand Island, NY). The proteins were
transferred to nitrocellulose, blocked in 5% nonfat dried
milk in phosphate-buffered saline with Tween 20 buffer for
1 hour at room temperature, and incubated with primary
antibody toward MMP-2 or MMP-9 (ab37150, ab38898;
Abcam, Cambridge, Mass) overnight. The blots were then
washed 3 times in phosphate-buffered saline with Tween
20 buffer, and incubated with horseradish peroxidase-conju-
gated antirabbit immunoglobulin-G secondary antibody at
a dilution of 1:10,000. Bands were visualized using chemilu-
menescence (GE Healthcare, Pittsburgh, Pa) according to
the manufacturer’s protocol.
Expression of MMP-2 and MMP-9 mRNA in VSMCs
was compared by real-time quantitative polymerase chain
reaction (PCR). Total RNA from VSMCs was isolated as
described above and cDNA was prepared using the high
capacity cDNA reverse transcription kit (Applied Bio-
systems, Life Technologies, Grand Island, NY), following
the manufacturer’s protocol. Real-time quantitative PCR
was conducted with an ABI-7500 real-time PCR system
(Applied Biosystems). mRNA were normalized to glyceral-
dehyde-3-phosphate dehydrogenase for each sample.
Dissociation curves were examined to rule out nonspeciﬁc
PCR ampliﬁcation. Primers and probes for MMP-2, MMP-
9, and GAPDH were obtained from Applied Biosystems
(assay ID: Hs01548727_m1, Hs00234579_m1, and
Hs02758991_g1, respectively). Gene expression in AAA
and CEA-VSMCs relative to NAA-VSMCs was calculated
using the 2DDCT method.
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1042.e4 Airhart et al October 2014Supplementary Fig 1 (online only). Heat map based on Affymetrix U133 GeneChip demonstrates 49 genes that are
informative in segregating the three microdissected regions of the arterial wall: intima, media, and adventitia. RNA was
extracted after microdissection of the arterial wall from three patients with abdominal aortic aneurysms (AAAs). The
RNA was converted to complimentary DNA and ampliﬁed before hybridization with the GeneChip. The B media
specimen from patient 1 was analyzed in duplicate due to poor ampliﬁcation of the A specimen.Supplementary Fig 2 (online only). Western blot analysis of
conditioned cell culture media for matrix metalloproteinase
(MMP)-2 and MMP-9. Vascular smooth muscle cells (VSMCs)
derived from abdominal aortic aneurysm (AAA), nondilated
abdominal aorta (NAA), and carotid endarterectomy (CEA)
tissues were cultured in serum-free media. The media was collected
after 7 days of cell growth, and equal volumes from each well
underwent Western blot analysis for MMP-2 and MMP-9. In
media from VSMC-only cultures, relatively equal amounts of
MMP-2 (72 kD) were observed. No MMP-9 was detected in the
media containing only VSMC (n ¼ 6). The error bars show the
standard error. *P < .05.
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Volume 60, Number 4 Airhart et al 1042.e5Supplementary Fig 3 (online only). Real-time polymerase chain reaction analysis was used to compare total
messenger RNA (mRNA) levels in phorbol 12-myristate 13-acetate-activated U937 monocytes cultured alone and in
the presence of vascular smooth muscle cells (VSMCs) derived from abdominal aortic aneurysm (AAA), nondilated
abdominal aorta (NAA), and carotid endarterectomy (CEA) tissues. The error bars represent the 95% conﬁdence
interval. Matrix metalloproteinase (MMP)-2 and MMP-9 expression by U937 cells was not signiﬁcantly affected by
coculture with VSMCs derived from AAA, CEA, or NAA tissue (n ¼ 3).
